
Venclexta Coupons & Savings Card – Discount Prices from $3877.04
My prescription
Edit
100MG, Venclexta (28 Tablets)
Select pharmacy

Walmart
$3877.04
COUPON PRICE
Albertsons
$3881.01
COUPON PRICE
Walgreens
$3888.03
COUPON PRICEVenclexta savings card
Show this card to your pharmacist
Walmart
$3877.04
BIN
ID
PCN
GRP
019876
LH59F52CE9
CHIPPO
LHX
Powered by
More prescriptions for leukemia
More prescriptions for leukemia
Price history for Venclexta
28 Tablets, 100MG
Average retail price for Venclexta
Average SaveHealth price for Venclexta
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Venclexta dosage forms
Dosage Quantity Price from Per unit 10MG 2 Tablets $8.83 $4.42 10MG 14 Tablets $175.74 $12.55 50MG 1 Tablet $50.60 $50.60 50MG 7 Tablets $468.13 $66.88 100MG 28 Tablets $3877.04 $138.47 100MG 1 Tablet $120.15 $120.15 100MG 120 Tablets $16608.25 $138.40 100MG 180 Tablets $24908.63 $138.38
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 10MG | 2 Tablets | $8.83 | $4.42 |
| 10MG | 14 Tablets | $175.74 | $12.55 |
| 50MG | 1 Tablet | $50.60 | $50.60 |
| 50MG | 7 Tablets | $468.13 | $66.88 |
| 100MG | 28 Tablets | $3877.04 | $138.47 |
| 100MG | 1 Tablet | $120.15 | $120.15 |
| 100MG | 120 Tablets | $16608.25 | $138.40 |
| 100MG | 180 Tablets | $24908.63 | $138.38 |
Is VENCLEXTA considered chemotherapy?
VENCLEXTA (venetoclax) is not considered traditional chemotherapy. It is a targeted therapy known as a BCL-2 inhibitor, which works by helping to restore the process of apoptosis, or programmed cell death, in cancer cells.
What is the drug VENCLEXTA used for?
VENCLEXTA is used for the treatment of certain types of blood cancers, specifically chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and acute myeloid leukemia (AML). It works by targeting and inhibiting a protein that helps cancer cells survive, thereby promoting their destruction.
Is VENCLEXTA an immunosuppressant?
VENCLEXTA (venetoclax) is not classified as an immunosuppressant. It is a medication used primarily in the treatment of certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). It works by inhibiting a protein called BCL-2, which helps cancer cells survive.
What is the life expectancy of VENCLEXTA patients?
The life expectancy of patients taking VENCLEXTA (venetoclax) can vary significantly based on several factors, including the type and stage of cancer being treated, the patient's overall health, response to treatment, and other individual circumstances. Clinical trials and studies provide data on progression-free survival and overall survival rates, but these are averages and may not predict individual outcomes. It is important for patients to discuss their specific prognosis with their healthcare provider, who can provide information tailored to their unique situation.
Is venetoclax an immunosuppressant?
Venetoclax is not classified as an immunosuppressant. It is a medication used primarily in the treatment of certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). It works by inhibiting the BCL-2 protein, which helps cancer cells survive.
